Logo image of FRPT

FRESHPET INC (FRPT) Stock Fundamental Analysis

NASDAQ:FRPT - Nasdaq - US3580391056 - Common Stock - Currency: USD

107.58  +7.3 (+7.28%)

After market: 109.69 +2.11 (+1.96%)

Fundamental Rating

4

Overall FRPT gets a fundamental rating of 4 out of 10. We evaluated FRPT against 90 industry peers in the Food Products industry. FRPT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FRPT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

FRPT had positive earnings in the past year.
In the past year FRPT had a positive cash flow from operations.
In the past 5 years FRPT always reported negative net income.
In multiple years FRPT reported negative operating cash flow during the last 5 years.
FRPT Yearly Net Income VS EBIT VS OCF VS FCFFRPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.88%, FRPT is in line with its industry, outperforming 50.00% of the companies in the same industry.
The Return On Equity of FRPT (4.32%) is comparable to the rest of the industry.
The Return On Invested Capital of FRPT (1.95%) is worse than 61.90% of its industry peers.
Industry RankSector Rank
ROA 2.88%
ROE 4.32%
ROIC 1.95%
ROA(3y)-3.79%
ROA(5y)-2.54%
ROE(3y)-4.47%
ROE(5y)-3.06%
ROIC(3y)N/A
ROIC(5y)N/A
FRPT Yearly ROA, ROE, ROICFRPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 -4

1.3 Margins

FRPT has a better Profit Margin (4.75%) than 65.48% of its industry peers.
With a Operating Margin value of 3.83%, FRPT perfoms like the industry average, outperforming 51.19% of the companies in the same industry.
With an excellent Gross Margin value of 38.76%, FRPT belongs to the best of the industry, outperforming 89.29% of the companies in the same industry.
In the last couple of years the Gross Margin of FRPT has declined.
Industry RankSector Rank
OM 3.83%
PM (TTM) 4.75%
GM 38.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.44%
GM growth 5Y-6.56%
FRPT Yearly Profit, Operating, Gross MarginsFRPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRPT is destroying value.
FRPT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FRPT Yearly Shares OutstandingFRPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
FRPT Yearly Total Debt VS Total AssetsFRPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

2.2 Solvency

FRPT has an Altman-Z score of 6.39. This indicates that FRPT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.39, FRPT belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
A Debt/Equity ratio of 0.41 indicates that FRPT is not too dependend on debt financing.
FRPT has a Debt to Equity ratio (0.41) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 6.39
ROIC/WACC0.22
WACC8.84%
FRPT Yearly LT Debt VS Equity VS FCFFRPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.72 indicates that FRPT has no problem at all paying its short term obligations.
FRPT has a better Current ratio (4.72) than 91.67% of its industry peers.
A Quick Ratio of 3.91 indicates that FRPT has no problem at all paying its short term obligations.
FRPT has a better Quick ratio (3.91) than 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 4.72
Quick Ratio 3.91
FRPT Yearly Current Assets VS Current LiabilitesFRPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

FRPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 232.39%, which is quite impressive.
EPS 1Y (TTM)232.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.13%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%21.95%

3.2 Future

FRPT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.00% yearly.
The Revenue is expected to grow by 19.48% on average over the next years. This is quite good.
EPS Next Y55.41%
EPS Next 2Y53.94%
EPS Next 3Y44.78%
EPS Next 5Y42%
Revenue Next Year24.46%
Revenue Next 2Y24.08%
Revenue Next 3Y23.02%
Revenue Next 5Y19.48%

3.3 Evolution

FRPT Yearly Revenue VS EstimatesFRPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
FRPT Yearly EPS VS EstimatesFRPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 114.45, the valuation of FRPT can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of FRPT indicates a slightly more expensive valuation: FRPT is more expensive than 61.90% of the companies listed in the same industry.
FRPT is valuated expensively when we compare the Price/Earnings ratio to 29.53, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 73.64, FRPT can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FRPT is on the same level as its industry peers.
FRPT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.65, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 114.45
Fwd PE 73.64
FRPT Price Earnings VS Forward Price EarningsFRPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FRPT indicates a slightly more expensive valuation: FRPT is more expensive than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 49.69
FRPT Per share dataFRPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as FRPT's earnings are expected to grow with 44.78% in the coming years.
PEG (NY)2.07
PEG (5Y)N/A
EPS Next 2Y53.94%
EPS Next 3Y44.78%

More info and screens

0

5. Dividend

5.1 Amount

FRPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FRESHPET INC

NASDAQ:FRPT (2/24/2025, 8:00:00 PM)

After market: 109.69 +2.11 (+1.96%)

107.58

+7.3 (+7.28%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-20 2025-02-20/bmo
Earnings (Next)05-05 2025-05-05/bmo
Inst Owners109.13%
Inst Owner Change-91.63%
Ins Owners1.71%
Ins Owner Change0.21%
Market Cap5.22B
Analysts82.4
Price Target171.94 (59.83%)
Short Float %8.65%
Short Ratio6.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)79.01%
Min EPS beat(2)37.3%
Max EPS beat(2)120.73%
EPS beat(4)4
Avg EPS beat(4)219.75%
Min EPS beat(4)37.3%
Max EPS beat(4)466.6%
EPS beat(8)7
Avg EPS beat(8)117.76%
EPS beat(12)7
Avg EPS beat(12)56.7%
EPS beat(16)7
Avg EPS beat(16)-53.59%
Revenue beat(2)1
Avg Revenue beat(2)-0.05%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)0.07%
Revenue beat(4)3
Avg Revenue beat(4)1.16%
Min Revenue beat(4)-0.18%
Max Revenue beat(4)3.34%
Revenue beat(8)5
Avg Revenue beat(8)1.02%
Revenue beat(12)7
Avg Revenue beat(12)0.45%
Revenue beat(16)8
Avg Revenue beat(16)-0.55%
PT rev (1m)-0.49%
PT rev (3m)8.75%
EPS NQ rev (1m)6.64%
EPS NQ rev (3m)6.64%
EPS NY rev (1m)2.1%
EPS NY rev (3m)7.01%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)0.12%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 114.45
Fwd PE 73.64
P/S 5.63
P/FCF N/A
P/OCF 37.06
P/B 5.11
P/tB 5.11
EV/EBITDA 49.69
EPS(TTM)0.94
EY0.87%
EPS(NY)1.46
Fwd EY1.36%
FCF(TTM)-1.35
FCFYN/A
OCF(TTM)2.9
OCFY2.7%
SpS19.12
BVpS21.04
TBVpS21.04
PEG (NY)2.07
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.88%
ROE 4.32%
ROCE 2.47%
ROIC 1.95%
ROICexc 2.41%
ROICexgc 2.41%
OM 3.83%
PM (TTM) 4.75%
GM 38.76%
FCFM N/A
ROA(3y)-3.79%
ROA(5y)-2.54%
ROE(3y)-4.47%
ROE(5y)-3.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.44%
GM growth 5Y-6.56%
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA 4.15
Cap/Depr 315.77%
Cap/Sales 22.23%
Interest Coverage 2.47
Cash Conversion 139.65%
Profit Quality N/A
Current Ratio 4.72
Quick Ratio 3.91
Altman-Z 6.39
F-Score7
WACC8.84%
ROIC/WACC0.22
Cap/Depr(3y)710.47%
Cap/Depr(5y)642.39%
Cap/Sales(3y)48.51%
Cap/Sales(5y)43.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)232.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.13%
EPS Next Y55.41%
EPS Next 2Y53.94%
EPS Next 3Y44.78%
EPS Next 5Y42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%21.95%
Revenue Next Year24.46%
Revenue Next 2Y24.08%
Revenue Next 3Y23.02%
Revenue Next 5Y19.48%
EBIT growth 1Y211.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year572.17%
EBIT Next 3Y117.34%
EBIT Next 5Y72.54%
FCF growth 1Y79.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y383.54%
OCF growth 3Y53.03%
OCF growth 5Y32.52%